Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«GAPDH

Below is an extended GAPDH publications listing. Click here to return to the gene page.

Gene Information from Publications

Publication Link Summary of findings
18340469 Observational study of gene-disease association. (HuGE Navigator)
15507493 Observational study of gene-disease association. (HuGE Navigator)
17989880 These results suggest that the polyQ domain, but not the polyP domain, plays a role in the sequestration of GAPDH to aggregates by mutant htt
17540725 Nitric oxide-mediated S-nitrosylation of GAPDH and subsequent nuclear translocation of GAPDH might function as a mediator of TRAIL-induced cell death in thyroid cancer cells.
17553795 Glyceraldehyde-3-phosphate dehydrogenase enhances transcriptional activity of androgen receptor in prostate cancer cells
15985219 evidence that GAPDH is an epithelial binding receptor for Porphyromonas gingivalis fimbriae
17121833 GAPDH interacts with transferrin and the GAPDH-transferrin complex is subsequently internalized into the early endosomes.
15485821 data suggest that glyceraldehyde-3-phosphate dehydrogenase (GAPDH) imparts a unique function necessary for membrane trafficking from vesicular tubular clusters (VTCs) that does not require GAPDH glycolytic activity
14630908 nuclear GAPDH has a role in the maintenance and/or protection of telomeres
12842822 Transcription factors bound to glutamine-responsive element in GAPDH promoter are C/EBPalpha and -delta.
17597534 Study observed no hypoxia-induced regulation of GAPDH expression in the 3 glioblastoma cell lines; also, GAPDH expression was similar in patient tumor samples of low-grade astrocytoma and glioblastoma, suggesting a lack of hypoxic regulation in vivo.
12008025 We identified a nuclear high molecular weight (HMW) GAPDH species in Huntington's disease cells, suggesting a connection between nuclear GAPDH function and huntingtin localization in this CAG expansion neuronal disease.
12921788 Glycoaldehyde inactivates GAPD.
16778134 OxLDL downregulated GAPDH via a H2O2-dependent decrease in protein stability. GAPDH protein damage resulted in marked depletion of cellular ATP levels.
16832079 The GAPD gene and its pseudogene may play a role in the development of late-onset Alzheimer disease. However, the effect, if any, is likely to be limited.
17027006 identified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a new interacting partner of TPPP/p25 within the alpha-synuclein positive Lewy body
16037232 Conditions associated with elevated intracellular methylglyoxal could modify GAPDH activity in vivo.
16186172 Amyloid-beta induces disulfide bonding and aggregation of GAPDH in Alzheimer's disease
12428732 GAPDH may be involved in the cellular phenotype of age-related neurodegenerative disorders--REVIEW
17387692 alpha-crystallin B, glyceraldehyde phosphate dehydrogenase (GAPDH), and alpha-enolase identified as significantly S-glutathionylated in Alzheimer's disease infeior parietal lobule
16082386 GAPDH is an integral part of the sarcolemmal K(ATP)-channel protein complex, where it couples glycolysis with the K(ATP)-channel activity.
17324518 A decrease in the dehydrogenase activity of GAPDH was noted in Alzheimer disease.
14730345 Thioredoxin regulates the expression of GAPDH.
12121569 GAPDH is not an ideal internal standard for specific gene expression in testicular tissue specimens
12697324 HIF-2alpha regulates glyceraldehyde-3-phosphate dehydrogenase gene expression in vascular endothelial cells.
15769908 Marked variability of GAPDH expression between tissue types which establish comparative levels of expression and can be used to add value to gene expression data in which GAPDH is used as the internal control.
16139273 Data show that the insertion of ferriprotoporphyrin IX (FP) into the red cell membranes exerts two opposite effects on membrane bound G3PD.
16515701 GAPDH is inaccurate to normalize mRNA levels in studies investigating the effect of bisphosphonates on gene expression; this gene could be considered a potential target to observe the effects of bisphosphonates on cancer cells
15507493 significant association between late-onset Alzheimer's disease and a compound genotype of the three GAPD genes
15907785 GAPDH modified by 4-hydroxy-2-nonenal and 4-hydroxy-2-hexenal is degraded by a giant serine protease, releasing the 23-kDa fragment, not by proteasome or TPP I
15716040 Subcellular interactions may mitigate oxidative stress-induced GAPDH modification in human aging.
12503091 dissociation of the GAPDH protein from the HMW species restores its enzymatic activity.
15746184 results demonstrate that glyceraldehyde-3-phosphate dehydrogenase, a glycolytic and microtubule binding protein, co-localized to neurofibrillary tangles and immunoprecipitated with paired helical filament-tau
16474839 GAPDH might be involved in cell cycle regulation by modulating cyclin B-cdk1 activity.
17015754 TPI and GAPDH may be candidate Ags for an autoimmune response to neurons and axons in multiple sclerosis.
14515148 Glyceraldehyde-3-phosphate dehydrogenase might be a novel target for vaccinia anti-apoptotic modulation.
15001839 GAPDH mRNA expression was correlated with evidence of tumor progression in thymoma.
12887926 The p38/gapdh component of OCA-S binds directly to OCT1.

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.